Gaithersburg, Maryland and SEOUL, Korea,- Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced a novel real-time array technology designed specifically to accelerate the development of Point of Care Testing (POCT). The novel real-time array technology successfully eliminates burdensome, time-consuming steps that normally follow PCR amplification and that are […]
KARLSRUHE, Germany –– Bruker today announces a standardized nuclear magnetic resonance (NMR) spectroscopy platform for its clinical and diagnostics partners that enables cost-effective, high-performance NMR clinical screening and IVD-by-NMR discovery, development and validation of novel NMR assays. The new AVANCE-IVDr system, presently for research use only, is a complete, proven and standardized platform for NMR […]
Menlo Park, CA – Personalis today announced the appointment of Adam Lowe as Vice President of Marketing. Mr. Lowe’s extensive experience building commercial and scientific teams in the genomics field will be critical in driving the company’s product and commercialization strategies. Mr. Lowe brings over 20 years of life science experience in marketing, product development, […]
BOSTON –– Pathogenica Inc. announced today it had entered into an agreement with Illumina(NASDAQ:ILMN), whereby the parties will co-market in the Asia Pacific region a new version of Pathogenica’s HAI BioDetection kit compatible with Illumina’s MiSeq benchtop sequencing system. The combined solution will enable users to identify an expanded panel of bacteria and drug resistance […]
La Jolla, Calif. — California Healthcare Institute (CHI) announced today the election of four senior executives to serve on its board of directors: Peter Claude, partner at PwC US; Dr. Michael Marletta, president and CEO of The Scripps Research Institute (TSRI); Alan Mendelson, partner at Latham & Watkins; and Dr. Marc Tremblay, president, clinical diagnostics […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ:LIFE – News) today announced that the company has signed an agreement to collaborate with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for current and future companion diagnostics projects. The current agreement constitutes the first collaboration between the two companies and represents another step in Life Technologies’ […]
Milford, Massachusetts,– SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, announced it has introduced a new AccuSet™ anti-Toxoplasma performance panel. This is the newest addition to the SeraCare line of performance panels designed to help IVD manufacturers effectively challenge new assays […]
AUSTIN, Texas, — Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA and European clearance for a new version of xTAG CYP2D6 Kit. Additionally the company has submitted xTAG 2C19 Kit to FDA for review. Luminex is advancing its pharmacogenetic initiative for improved patient care. “Test results that inform a physician on how […]
GERMANTOWN, Maryland, and HILDEN, Germany, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim’s new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC […]
ST. LOUIS – C2N Diagnostics (C2N) today announced that it has signed a collaborative research and a global, exclusive supplier agreement with Cambridge Isotope Laboratories, Inc (CIL). The partnership guarantees C2N’s future access to mass quantities of highly enriched stable isotopes at predictable prices. These stable isotopes are key reagents to C2N’s platform of Stable […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
